Table 2.
Cox proportional regression analysis to investigate the correlations of sirtuins and overall survival in patients with NSCLC
SIRTs | Univariate analysis
|
Multivariate analysis*
|
||||||
---|---|---|---|---|---|---|---|---|
P-value | HR | 95% CI | P-value | HR | 95% CI | |||
SIRT1 | 0.352 | 0.902 | 0.725 | 1.121 | 0.956 | 1.007 | 0.787 | 1.288 |
SIRT2 | 0.007 | 0.736 | 0.588 | 0.920 | 0.005 | 0.697 | 0.543 | 0.894 |
SIRT3 | 0.244 | 0.865 | 0.677 | 1.104 | 0.568 | 0.922 | 0.696 | 1.220 |
SIRT4 | 0.043 | 0.761 | 0.584 | 0.992 | 0.255 | 0.842 | 0.626 | 1.132 |
SIRT5 | 0.109 | 0.837 | 0.673 | 1.040 | 0.128 | 0.828 | 0.650 | 1.056 |
SIRT6 | 0.044 | 0.780 | 0.612 | 0.994 | 0.009 | 0.684 | 0.514 | 0.911 |
SIRT7 | 0.253 | 0.881 | 0.708 | 1.095 | 0.305 | 0.878 | 0.686 | 1.125 |
Note:
The potential confounding factors were age, M, N, and T stage. Bold font: P<0.05 demonstrated by Cox proportional regression analysis.
Abbreviation: TCGA, The Cancer Genome Atlas; NSCLC, non-small cell lung cancer; SIRT1, sirtuin 1; SIRT2, sirtuin 2; SIRT3, sirtuin 3; SIRT4, sirtuin 4; SIRT5, sirtuin 5; SIRT6, sirtuin 6; SIRT7, sirtuin 7; HR, hazard ratio; CI, confidence interval.